Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays

Litchfield, 2003, Protein kinase CK2: structure, regulation and role in cellular decisions of life and death, Biochem J, 369, 1, 10.1042/bj20021469

St-Denis, 2009, Protein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival, Cell Mol Life Sci, 66, 1817, 10.1007/s00018-009-9150-2

Filhol, 2009, Protein kinase CK2 in health and disease: cellular functions of protein kinase CK2: a dynamic affair, Cell Mol Life Sci, 66, 1830, 10.1007/s00018-009-9151-1

Duncan, 2008, Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2, Biochim Biophys Acta, 1784, 33, 10.1016/j.bbapap.2007.08.017

Pallares, 2009, CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation, Am J Pathol, 174, 287, 10.2353/ajpath.2009.080552

Landesman-Bollag, 2001, Protein kinase CK2 in mammary gland tumorigenesis, Oncogene, 20, 3247, 10.1038/sj.onc.1204411

Romieu-Mourez, 2001, Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer, Cancer Res, 61, 3810

Yde, 2007, Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT, Cancer Lett, 256, 229, 10.1016/j.canlet.2007.06.010

Laudet, 2007, Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction, Biochem J, 408, 363, 10.1042/BJ20070825

Zhu, 2010, Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth, Mol Cell Biochem, 333, 159, 10.1007/s11010-009-0216-0

Laramas, 2007, Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer, Eur J Cancer, 43, 928, 10.1016/j.ejca.2006.11.021

Charpin, 1994, Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators, J Natl Cancer Inst, 86, 1539, 10.1093/jnci/86.20.1539

Garcia, 2007, C-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays, Br J Cancer, 96, 329, 10.1038/sj.bjc.6603569

Garcia, 2007, Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype, Hum Pathol, 38, 830, 10.1016/j.humpath.2006.11.015

Charpin, 2009, A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays, Int J Cancer, 124, 2124, 10.1002/ijc.24177

Altman, 1994, Dangers of using “optimal” cutpoints in the evaluation of prognostic factors, J Natl Cancer Inst, 86, 829, 10.1093/jnci/86.11.829

Royston, 2006, Dichotomizing continuous predictors in multiple regression: a bad idea, Stat Med, 25, 127, 10.1002/sim.2331

Filhol, 1992, Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation, J Biol Chem, 267, 20577, 10.1016/S0021-9258(19)36725-0

Ruzzene, 2010, Addiction to protein kinase CK2: a common denominator of diverse cancer cells?, Biochim Biophys Acta, 1804, 499, 10.1016/j.bbapap.2009.07.018

Ji, 2009, EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin, Mol Cell, 36, 547, 10.1016/j.molcel.2009.09.034

Silva, 2010, Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors, Haematologica, 95, 674, 10.3324/haematol.2009.011999

Di Maira, 2009, Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells, Cell Mol Life Sci, 66, 3363, 10.1007/s00018-009-0108-1

Timofeeva, 2006, Serine-phosphorylated STAT1 is a prosurvival factor in Wilms’ tumor pathogenesis, Oncogene, 25, 7555, 10.1038/sj.onc.1209742

Soufi, 2009, CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding, Nucleic Acids Res, 37, 3288, 10.1093/nar/gkp197

Kallergi, 2009, Hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients, Breast Cancer Res, 11, R84, 10.1186/bcr2452

Mottet, 2005, Role for casein kinase 2 in the regulation of HIF-1 activity, Int J Cancer, 117, 764, 10.1002/ijc.21268